Alexandros A Drosos (Paraskevi Voulgari, Eleftherios Pelechas, E Pelechas)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 29

Top Venues

Rheumatology international

Rheumatology and therapy

Journal of clinical medicine

Current rheumatology reports

Scarborough General Hospital

Universitatea de Medicina si Farmacie Gr T Popa Iasi (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Scarborough General Hospital Jul 29 2015 - Aug 07 2015

United Kingdom

Senior House Officer :: Accident and Emergency

Scarborough General Hospital Jun 01 2015 - Jun 07 2015

United Kingdom

Senior House Officer :: Accident and Emergency

Fairfield General Hospital Mar 16 2015 - Mar 24 2015

United Kingdom

Senior House Officer :: Accident and Emergency

Scarborough General Hospital Jul 01 2014 - Jul 14 2014

United Kingdom

Senior House Officer :: Accident and Emergency

Scarborough General Hospital May 26 2014 - Jun 13 2014

United Kingdom

Senior House Officer :: Accident and Emergency

Derriford Hospital Jan 23 2014 - Feb 28 2014

United Kingdom

Senior House Officer :: Internal Medicine

Leicester Royal Infirmary Jan 01 2014 - Jan 08 2014

United Kingdom

Senior House Officer :: Acute Medical Unit

Scarborough General Hospital Mar 11 2013 - Aug 06 2013

United Kingdom

Senior House Officer :: Accident and Emergency

Geniko Nosokomeio Kerkiras May 24 2011 - Feb 23 2013

Greece

Medical Resident :: Internal Medicine

Education History

Universitatea de Medicina si Farmacie Gr T Popa Iasi

Romania

PHD :: Epidemiology

Open University of Cyprus

Cyprus

MSC :: Management and Economics

Publications

Alexandros A Drosos, Alexandros A Drosos, Vassiliki Drossou, Paraskevi Vasileios Voulgari
Colchicine Against SARS-CoV-2 Infection: What is the Evidence? Rheumatology and therapy 9 (2) (2022)
Alexandros A Drosos, Paraskevi Vasileios Voulgari, Alexandros A Drosos
TNFα inhibitor biosimilars associated with alopecia areata. Case-based review. Rheumatology international 42 (6) (2022)
Alexandros A Drosos, Alexandros A Drosos, Paraskevi Vasileios Voulgari
Long COVID from rheumatology perspective: a simple mimicker or promoter of autoimmunity? Clinical rheumatology 41 (3) (2022)
Alexandros A Drosos, Alexandros A Drosos
State-of-the-art glucocorticoid-targeted drug therapies for the treatment of rheumatoid arthritis. Expert opinion on pharmacotherapy 23 (6) (2022)
Alexandros A Drosos, Alexandros A Drosos, Paraskevi Vasileios Voulgari
A Patient with Symmetrical Polyarthritis. The Value of Conventional Radiography for a Correct Diagnosis. Rheumatology and therapy 9 (2) (2022)
Alexandros A Drosos, Alexandros A Drosos, Vassiliki Drossou, Paraskevi Vasileios Voulgari
A Response to: Letter to the Editor Regarding the Article: "Colchicine Against SARS-CoV-2 Infection: What is the Evidence?" Rheumatology and therapy 9 (4) (2022)
Fotini B Karassa, Konstantinos I Bougioukas, Alexandros A Drosos, Anastasia Skalkou, Evangelia Argyriou, Anna-Bettina Haidich
Pharmacological treatment for connective tissue disease-associated interstitial lung involvement: Protocol for an overview of systematic reviews and meta-analyses. PloS one 17 (8) (2022)
Alexandros A Drosos, Vassiliki Drossou, Paraskevi Vasileios Voulgari, Alexandros A Drosos
COVID-19 in patients with gout on colchicine. Rheumatology international 41 (8) (2021)
Alexandros A Drosos, Athanasios Georgiadis, Paraskevi Vasileios Voulgari, Alexandros A Drosos
Methotrexate and interstitial lung disease. Is there a real causative factor? Rheumatology international 41 (11) (2021)
Venetsanopoulou I Aliki, Euripidis Kaltsonoudis, Alexandros A Drosos, Vassiliki Drossou, Panagiota G Karagianni, Athanasios Kavvadias, Paraskevi Vasileios Voulgari, Alexandros A Drosos
Use of conventional synthetic and biologic disease-modifying anti-rheumatic drugs in patients with rheumatic diseases contracting COVID-19: a single-center experience. Rheumatology international 41 (5) (2021)
Konstantinos Ioannis Tsamis, Constantinos Boutsoras, Evripidis Kaltsonoudis, Alexandros A Drosos, Ilias P Nikas, Yannis Vasileios Simos, Paraskevi V Voulgari, Ioannis Sarmas
Clinical features and diagnostic tools in idiopathic inflammatory myopathies. Critical reviews in clinical laboratory sciences (2021)
Alexandros A Drosos, Eleftherios Pelechas, Paraskevi V Voulgari
Seronegative Erosive Arthritis Following SARS-CoV-2 Infection. Rheumatology and therapy (2021)
Alexandros A Drosos, Paraskevi Vasileios Voulgari, Alexandros A Drosos
Insulin resistance in patients with rheumatoid arthritis. Rheumatology international 41 (6) (2021)
Alexandros A Drosos, Paraskevi V Voulgari, Alexandros A Drosos
Preclinical discovery and development of adalimumab for the treatment of rheumatoid arthritis. Expert opinion on drug discovery 16 (3) (2020)
Alexandros A Drosos, Alexandros A Drosos, Paraskevi Vasileios Voulgari
Treatment strategies are more important than drugs in the management of rheumatoid arthritis. Clinical rheumatology 39 (4) (2020)
Alexandros A Drosos, Alexandros A Drosos, Paraskevi Vasileios Voulgari
Radiological Findings of the Cervical Spine in Rheumatoid Arthritis: What a Rheumatologist Should Know. Current rheumatology reports 22 (6) (2020)
Alexandros A Drosos, Alexandros A Drosos, Euripidis Kaltsonoudis, Paraskevi Vasileios Voulgari
Therapeutic Options and Cost-Effectiveness for Rheumatoid Arthritis Treatment. Current rheumatology reports 22 (8) (2020)
Alexandros A Drosos, Paraskevi V Voulgari, Alexandros A Drosos
Recent advances in the opioid mu receptor based pharmacotherapy for rheumatoid arthritis. Expert opinion on pharmacotherapy 21 (17) (2020)
Alexandros A Drosos, Paraskevi Vasileios Voulgari, Alexandros A Drosos
Occupational mimics of rheumatoid arthritis: hair dye-induced arthritis. Rheumatology international 41 (4) (2020)
Venetsanopoulou I Aliki, Alexandros A Drosos, Paraskevi Vasileios Voulgari, Alexandros A Drosos
The lipid paradox in rheumatoid arthritis: the dark horse of the augmented cardiovascular risk. Rheumatology international 40 (8) (2020)
George Markousis-Mavrogenis, Michael T Nurmohamed, Loukia Koutsogeorgopoulou, Theodoros Dimitroulas, Gkikas Katsifis, Vasiliki Vartela, Dimos-Dimitrios D Mitsikostas, Genovefa Kolovou, Maria G G Tektonidou, Alexandros A Drosos, Petros P Sfikakis, George D Kitas, Sophie I Mavrogeni
Current understanding and future perspectives of brain-heart-kidney axis in psoriatic arthritis. Rheumatology international 40 (9) (2020)
Alexandros A Drosos, Tereza Memi, Theodora E Markatseli, Paraskevi Vasileios Voulgari, Alexandros A Drosos
Adalimumab-induced myasthenia gravis: case-based review. Rheumatology international 40 (11) (2020)
Alexandros A Drosos, Alexandros A Drosos
Etanercept biosimilar SB-4. Expert opinion on biological therapy 19 (3) (2019)
Alexandros A Drosos, Alexandros A Drosos, Paraskevi Vasileios Voulgari
Conventional radiography of the hands and wrists in rheumatoid arthritis. What a rheumatologist should know and how to interpret the radiological findings. Rheumatology international 39 (8) (2019)
Alexandros A Drosos, Paraskevi V Voulgari, Alexandros A Drosos
Golimumab for Rheumatoid Arthritis. Journal of clinical medicine 8 (3) (2019)
Alexandros A Drosos, Euripidis Kaltsonoudis, Paraskevi Vasileios Voulgari, Alexandros A Drosos
Unmet needs in the treatment of ankylosing spondylitis: a long-term observational study from a single university center. Rheumatology international 39 (4) (2019)
Alexandros A Drosos, Alexandros A Drosos, Paraskevi Vasileios Voulgari
Rheumatoid Arthritis Treatment. A Back to the Drawing Board Project or High Expectations for Low Unmet Needs? Journal of clinical medicine 8 (8) (2019)
Alexandros A Drosos, Paraskevi Vasileios Voulgari, Alexandros A Drosos
ABP 501 for the treatment of rheumatoid arthritis. Expert opinion on biological therapy 18 (3) (2018)
Alexandros A Drosos, Alexandra Papoudou-Bai, Paraskevi Vasileios Voulgari, Alexandros A Drosos
Granuloma annulare development in a patient with rheumatoid arthritis treated with tocilizumab: case-based review. Rheumatology international 39 (2) (2018)

Alexandros A Drosos.css-eqlu8i{font-size:small;padding-left:4px;} (Paraskevi Voulgari, Eleftherios Pelechas, E Pelechas)

Publication Activity (10 Years)

Top Topics

Top Venues

Alexandros A Drosos (Paraskevi Voulgari, Eleftherios Pelechas, E Pelechas)